EMA Receives Application for Conditional Marketing Authorisation of Moderna COVID-19 Vaccine

4. Dezember 2020 – Since the assessment of Moderna COVID-19 vaccine will proceed under an accelerated timeline, an opinion on the marketing authorisation could be issued within weeks.

For further information, see here.